Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by T. J. Barber
Correction To: CSF Inflammatory Markers and Neurocognitive Function After Addition of Maraviroc to Monotherapy Darunavir/Ritonavir in Stable HIV Patients: The CINAMMON Study
Journal of NeuroVirology
Virology
Neurology
Cellular
Molecular Neuroscience
Implanon(R) Failure and Antiretroviral Therapy
Journal of Family Planning and Reproductive Health Care
Related publications
Week 48 Efficacy and Central Nervous System Analysis of Darunavir/Ritonavir Monotherapy Versus Darunavir/Ritonavir With Two Nucleoside Analogues
AIDS
Infectious Diseases
Allergy
Immunology
Correction To: Evaluation of Cardiovascular Disease Risk in HIV‑1–Infected Patients Treated With Darunavir
Drugs in R and D
Pharmacology
Real-Life Study of Dual Therapy Based on Dolutegravir and Ritonavir-Boosted Darunavir in HIV-1-infected Treatment-Experienced Patients
PLoS ONE
Multidisciplinary
Model-Based Once-Daily Darunavir/Ritonavir Dosing Recommendations in Pediatric HIV-1-Infected Patients Aged≥3 to <12 Years
CPT: Pharmacometrics and Systems Pharmacology
Modeling
Simulation
Cardiovascular Medicine
Pharmacology
Cardiology
Effectiveness, Durability, and Safety of Darunavir/Ritonavir in HIV-1-infected Patients in Routine Clinical Practice in Italy: A Postauthorization Noninterventional Study
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Pharmacokinetics of Darunavir/Ritonavir and Ketoconazole Following Co-Administration in HIV-healthy Volunteers
British Journal of Clinical Pharmacology
Pharmacology
Antiretroviral Simplification With Darunavir/Ritonavir Monotherapy in Routine Clinical Practice: Safety, Effectiveness, and Impact on Lipid Profile
PLoS ONE
Multidisciplinary
Severe Dyslipidaemia After the Addition of Raltegravir to a Lopinavir/Ritonavir-Containing Regimen
Antiviral Therapy
Infectious Diseases
Pharmacology
Pharmacokinetics of Darunavir/Ritonavir in Asian HIV-1 Infected Children Aged >=7 Years
Antiviral Therapy
Infectious Diseases
Pharmacology